ALBANY, N.Y., Sept. 24, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it amended its existing credit facilities and successfully refinanced its long-term debt. This new lending facility will improve AngioDynamics' capital structure and provide greater flexibility to support the execution of its growth strategy. The new debt facility will reduce the Company's interest rate on its credit facility by up to 75 basis points and improve its cash flow while extending the maturity of the debt.
Help employers find you! Check out all the jobs and post your resume.
